Finally, we found that the addition of WBC, LDH, Ki-67 index, and ECOG status as an addition to pre-treatment [18F]FDG-PET radiomic features clearly improved 2-year PFS prediction in a previous study of 107 MCL patients [32]. The gene discussed is MKI67; the disease is mantle cell lymphoma.